Used in treatment chronic hepatitis C
Natco Pharma announced that it has launched the first licensed generic version of ledipasvir + sofosbuvir combination of Nepal, under its brand name Hepcinat LP.Ledipasvir + Sofosbuvir is a two drug fixed-dose combination product that contains 90 mg of ledipasvir and 400 mg of sofosbuvir in a single tablet, and sold globally by Gilead Sciences Inc. under its brand HARVONI. It is indicated for the treatment of chronic hepatitis C (CHC) genotype 1 infection in adults. NATCO priced generic medicine, Hepcinat LP, at an MRP of INR 25,000 for a bottle of 28 tablets in Nepal.
Powered by Capital Market - Live News
